ACD/Labs now Offering a 30-day Free Trial of ACD/MS Fragmenter

Developer of chemistry software for the pharmaceutical and chemical industries, Advanced Chemistry Development, Inc., (ACD/Labs) is now offering a 30-day free trial of ACD/MS Fragmenter—a tool for predicting MS fragmentation of small organic molecules.

According to Company, ACD/MS Fragmenter makes it easy to review possible fragment ion structures, taking into account the type of ionization and the polarity of the molecule, then automatically applying standard fragmentation rules.

The results are clearly displayed in a fragmentation tree. Pathways of interest can be isolated for closer analysis, or used for reports and presentations with just a few mouse clicks.

The latest version of ACD/MS Fragmenter also includes the ability to predict fragmentation for negative ionization experiments, making it possible to use ACD/MS Fragmenter on a wider range of chemical compounds.

The free 30-day trial offered on the ACD/Labs website will allow mass spectrometrists to evaluate the capabilities of ACD/MS Fragmenter using virtually any small organic molecule drawn or imported into ACD/ChemSketch.

In addition to saving time and effort, the software’s use of accepted fragmentation rules derived from the literature eliminates intangible problems such as inexperience or bias that may get in the way when examining unusual, but possible, fragmentation pathways.